49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Functional Proteomic Analysis for Regulatory T Cell Surveillance of the HIV-1-Infected Macrophage

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Regulatory T cells (Treg) induce robust neuroprotection in murine models of neuroAIDS, in part, through eliciting anti-inflammatory responses for HIV-1-infected brain mononuclear phagocytes (MP; macrophage and microglia). Herein, using both murine and human primary cell cultures in proteomic and cell biologic tests, we report that Treg promotes such neuroprotection by an even broader range of mechanisms than previously seen including inhibition of virus release, killing infected MP, and inducing phenotypic cell switches. Changes in individual Treg-induced macrophage proteins were quantified by iTRAQ labeling followed by mass spectrometry identifications. Reduction in virus release paralleled the upregulation of interferon-stimulated gene 15, an ubiquitin-like protein involved in interferon-mediated antiviral immunity. Treg killed virus-infected macrophages through caspase-3 and granzyme and perforin pathways. Independently, Treg transformed virus-infected macrophages from an M1 to an M2 phenotype by down- and up- regulation of inducible nitric oxide synthase and arginase 1, respectively. Taken together, Treg affects a range of virus-infected MP functions. The observations made serve to challenge the dogma of solitary Treg immune suppressor functions and provides novel insights into how Treg affects adaptive immunosurveillance for control of end organ diseases, notably neurocognitive disorders associated with advanced viral infection.

          Abstract

          Proteomic changes in HIV-1-infected murine macrophages following cocultivation with murine Treg, Tcon, or cells cultured alone were quantified by iTRAQ. Macrophage functions that were effected by Treg included upregulation of interferon stimulated proteins, apoptosis, and functional transformation in surviving cells from an M1 to an M2 phenotype. The latter ultimately led to reductions in progeny virus release and in neuroprotective activities.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

          CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) are potent suppressors of the adaptive immune system, but their effects on innate immune cells are less well known. Here we demonstrate a previously uncharacterized function of Tregs, namely their ability to steer monocyte differentiation toward alternatively activated macrophages (AAM). AAM are cells with strong antiinflammatory potential involved in immune regulation, tissue remodeling, parasite killing, and tumor promotion. We show that, after coculture with Tregs, monocytes/macrophages display typical features of AAM, including up-regulated expression of CD206 (macrophage mannose receptor) and CD163 (hemoglobin scavenger receptor), an increased production of CCL18, and an enhanced phagocytic capacity. In addition, the monocytes/macrophages have reduced expression of HLA-DR and a strongly reduced capacity to respond to LPS in terms of proinflammatory mediator production (IL-1beta, IL-6, IL-8, MIP-1alpha, TNF-alpha), NFkappaB activation, and tyrosine phosphorylation. Mechanistic studies reveal that CD4(+)CD25(+)CD127(low)Foxp3(+) Tregs produce IL-10, IL-4, and IL-13 and that these cytokines are the critical factors involved in the suppression of the proinflammatory cytokine response. In contrast, the Treg-mediated induction of CD206 is entirely cytokine-independent, whereas the up-regulation of CD163, CCL18, and phagocytosis are (partly) dependent on IL-10 but not on IL-4/IL-13. Together these data demonstrate a previously unrecognized function of CD4(+)CD25(+)Foxp3(+) Tregs, namely their ability to induce alternative activation of monocytes/macrophages. Moreover, the data suggest that the Treg-mediated induction of AAM partly involves a novel, cytokine-independent pathway.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

            Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4(+) T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4(+)CD25(+) natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg subtypes display perforin-dependent cytotoxicity against autologous target cells, including activated CD4(+) and CD8(+) T cells, CD14(+) monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression

              Naturally occurring regulatory T cells (T reg cells) are a thymus-derived subset of T cells, which are crucial for the maintenance of peripheral tolerance by controlling potentially autoreactive T cells. However, the underlying molecular mechanisms of this strictly cell contact–dependent process are still elusive. Here we show that naturally occurring T reg cells harbor high levels of cyclic adenosine monophosphate (cAMP). This second messenger is known to be a potent inhibitor of proliferation and interleukin 2 synthesis in T cells. Upon coactivation with naturally occurring T reg cells the cAMP content of responder T cells is also strongly increased. Furthermore, we demonstrate that naturally occurring T reg cells and conventional T cells communicate via cell contact–dependent gap junction formation. The suppressive activity of naturally occurring T reg cells is abolished by a cAMP antagonist as well as by a gap junction inhibitor, which blocks the cell contact–dependent transfer of cAMP to responder T cells. Accordingly, our results suggest that cAMP is crucial for naturally occurring T reg cell–mediated suppression and traverses membranes via gap junctions. Hence, naturally occurring T reg cells unexpectedly may control the immune regulatory network by a well-known mechanism based on the intercellular transport of cAMP via gap junctions.
                Bookmark

                Author and article information

                Journal
                J Proteome Res
                pr
                jprobs
                Journal of Proteome Research
                American Chemical Society
                1535-3893
                1535-3907
                18 October 2010
                03 December 2010
                : 9
                : 12
                : 6759-6773
                Affiliations
                [1]Departments of Pharmacology and Experimental Neuroscience and Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States, and The Institute for Tissue Transplantation and Immunology, Jinan University, Guangzhou, Guangdong 510632, China
                Author notes
                [* ] To whom correspondence should be addressed. Howard E. Gendelman Department of Pharmacology and Experimental Neuroscience University of Nebraska Medical Center 985800 Nebraska Medical Center Omaha, NE 68198-5880. Phone: 402 559 8920. Fax: 402 559 3744. E-mail: hegendel@ 123456unmc.edu . Yaoying Zeng The Institute for Tissue Transplantation and Immunology Jinan University Guangzhou, Guangdong 510632, China. Phone: 8620-85226219. E-mail: zengyaoying@ 123456gmail.com .
                [†]

                These authors contributed equally to this manuscript.

                [‡]

                Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center.

                [§]

                Jinan University.

                [∥]

                Department of Biostatistics, University of Nebraska Medical Center.

                Article
                10.1021/pr1009178
                3108468
                20954747
                a448c680-2f42-49ee-a4d5-432328480bf2
                Copyright © 2010 American Chemical Society

                This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.

                History
                : 7 September 2010
                : 04 November 2010
                : 03 December 2010
                : 18 October 2010
                Funding
                National Institutes of Health, United States
                Categories
                Article
                Custom metadata
                pr1009178
                pr-2010-009178

                Molecular biology
                human immunodeficiency virus type one (hiv-1),regulatory t cells,itraq,hiv-1 associated neurocognitive disorders,vesicular stomatitis virus,cytotoxicity,bone marrow derived macrophages

                Comments

                Comment on this article